About this site

Hi, Biotech is an independent biotech publication launched in October 2026. We cover the science getting funded: vaccines, infectious disease, manufacturing, and the money that moves all of it. One briefing, every Tuesday.

Editorial standards

Everything published under our byline is written from scratch and fact-checked against primary sources: regulatory filings, trial registries, peer-reviewed literature and company disclosures. We do not republish or syndicate content from other outlets.

About the press archive

Before this publication existed, the hibiotech.com domain was home to a working biotech company. This site carries that company's historical press archive, republished for research and archival purposes with attribution. Hi, Biotech is not affiliated with, endorsed by or connected to Hawaii Biotech, Inc. or any other company. Copyright in the archived materials remains with their original owner.

Contact

Reach the newsroom at newsroom@hibiotech.com.